Cutler Group’s Avanos Medical AVNS Stock Holding History

Cutler Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,300	Closed	-$2K	–	6610
2016 Q1	$2K	Buy	9,300 +9,000	+3,000%	+$240K	﹤0.01%	5490
2015 Q4	$1K	Buy	+300	New	+$9.33K	﹤0.01%	5836

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutler Group's AVNS Position: Q4 2018 in Review

Cutler Group sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,725 shares — an estimated $255K sold.

Cutler Group first reported a position in AVNS in Q4 2015 and held it in 9 quarters. The position peaked at $255K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Cutler Group reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Cutler Group sold 3,725 Avanos Medical shares in Q4 2018, an estimated $255K.
Cutler Group first reported a position in Avanos Medical in Q4 2015 and held it in 9 quarters.
Cutler Group's Avanos Medical position peaked at $255K in Q3 2018.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Cutler Group's 13F filing for Q4 2018, filed 5 Feb 2019.